Ivo A. Hendriks
Impact in
- Oncology top 2%
- Peptidase Inhibition and Analysis
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways
- DNA Repair Mechanisms
- RNA modifications and cancer
- Glycosylation and Glycoproteins Research
- Genomics and Chromatin Dynamics
Papers in
-
- Ubiquitin and proteasome pathways 27
- DNA Repair Mechanisms 14
- RNA modifications and cancer 9
- Genomics and Chromatin Dynamics 6
- CRISPR and Genetic Engineering 5
- Oncology 19
- PARP inhibition in cancer therapy 8
- Peptidase Inhibition and Analysis 7
- Cancer-related Molecular Pathways 5
- Co-authors
- Alfred C.O. Vertegaal (13 shared papers)Michael L. Nielsen (36 shared papers)Matthias Mann (3 shared papers)Matty Verlaan–de Vries (3 shared papers)Lars Juhl Jensen (4 shared papers)David Lyon (3 shared papers)Sara C. Buch-Larsen (9 shared papers)Rochelle C. J. D’Souza (2 shared papers)
- Journals
- Molecular Cell (8 papers)Nature Communications (7 papers)Nature Structural & Molecular Biology (6 papers)Cell Reports (6 papers)The EMBO Journal (4 papers)
- Partner nations
- DenmarkNetherlandsUnited Kingdom
In The Last Decade
Ivo A. Hendriks
49 papers receiving 3.1k citations
Ivo A. Hendriks's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 1.2k
- Molecular Biology 2.7k
- Physiology 95
- Immunology 393
- Cell Biology 298
Countries citing papers authored by Ivo A. Hendriks
This map shows the geographic impact of Ivo A. Hendriks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivo A. Hendriks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivo A. Hendriks more than expected).
Fields of papers citing papers by Ivo A. Hendriks
This network shows the impact of papers produced by Ivo A. Hendriks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivo A. Hendriks. The network helps show where Ivo A. Hendriks may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivo A. Hendriks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Uncovering global SUMOylation signaling networks in a site-specific manner Hit paper breakdown → | 2014 | 390 |
| 2 | A comprehensive compilation of SUMO proteomics Hit paper breakdown → | 2016 | 372 |
| 3 | 2017 | 270 | |
| 4 | 2010 | 260 | |
| 5 | 2018 | 155 | |
| 6 | 2014 | 147 | |
| 7 | 2018 | 137 | |
| 8 | 2019 | 124 | |
| 9 | 2015 | 108 | |
| 10 | 2012 | 96 | |
| 11 | 2015 | 95 | |
| 12 | 2020 | 86 | |
| 13 | 2019 | 79 | |
| 14 | 2015 | 77 | |
| 15 | 2021 | 74 | |
| 16 | 2015 | 69 | |
| 17 | 2020 | 60 | |
| 18 | 2021 | 45 | |
| 19 | 2015 | 36 | |
| 20 | 2020 | 36 |
About Ivo A. Hendriks
Ivo A. Hendriks is a scholar working on Molecular Biology, Oncology, Epidemiology, Cell Biology and Spectroscopy, having authored 52 papers that have together received 3.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (27 papers), DNA Repair Mechanisms (14 papers), RNA modifications and cancer (9 papers), PARP inhibition in cancer therapy (8 papers), Peptidase Inhibition and Analysis (7 papers), Genomics and Chromatin Dynamics (6 papers), CRISPR and Genetic Engineering (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Oncology (1.2k citations), Molecular Biology (2.7k citations), Physiology (95 citations), Immunology (393 citations) and Cell Biology (298 citations). Ivo A. Hendriks has collaborated with scholars based in Denmark, Netherlands and United Kingdom. Frequent co-authors include Alfred C.O. Vertegaal, Michael L. Nielsen, Matthias Mann, Matty Verlaan–de Vries, Lars Juhl Jensen, David Lyon, Sara C. Buch-Larsen, Rochelle C. J. D’Souza, Bing Yang and Jesper V. Olsen. Their work appears in journals such as Molecular Cell, Nature Communications, Nature Structural & Molecular Biology, Cell Reports and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.